Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

A Study of ZN-c3 in Combination With Gemcitabine in Subjects With Osteosarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04833582
Recruitment Status : Recruiting
First Posted : April 6, 2021
Last Update Posted : February 1, 2023
Information provided by (Responsible Party):
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 30, 2023
Estimated Study Completion Date : December 30, 2023